Published in AIDS Weekly, September 19th, 2005
"It has been demonstrated that, in patients treated by protease-inhibitor-based regimen, intermittent viremia occurred frequently and was associated with higher concentrations of residual replication but not with virological failure.
"Risk factors associated with intermittent viremia and its impact in patients treated by nonnucleoside-reverse-transcriptase-inhibitor-based (NNRTI) regimen need to be evaluated," scientists in France report.
"We analyzed the occurrence of blips (one HIV-1 RNA >50 copies/mL with a subsequent value <50...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.